Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) Fair Value & Analysis
Basic Materials · IN · Market cap ₹8.3B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price −3.8% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹384.00 – ₹694.30 · fair‑value band ₹669.60 – ₹1,077 · the ₹492.20 price screens below the ₹892.80 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) currently trades at ₹492.20, while our model-based Fair Value estimate is ₹892.80 — implying the stock looks roughly 81.4% undervalued today. We read business quality at 63/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Sree Rayalaseema Hi-Strength Hypo Limited generated revenue of ₹6.7B at a net margin of 13.5%. Revenue grew 1.7% year over year. It earns a return on equity of 9.4%. The balance sheet holds a net cash position of ₹4.3B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Sree Rayalaseema Hi-Strength Hypo Limited produces and sells industrial chemicals in India. It operates through three segments: Chemical Manufacturing; Power Generation; and Trading in Coal. The company provides sulphuric, chlorosulphonic, hydrochloric, and monochloro acetic acids; purichlor, chloramine, oleum, sodium dichloroisocyanurate, and hydrogen gas; and aluminum sulphate, stable bleaching powder, sodium hydride, sodium methoxide powder and solution, and water treatment chemicals. It is involved in the generation and distribution of power through thermal, wind, and solar plants; and coal trading business. The company also exports its products. Sree Rayalaseema Hi-Strength Hypo Limited was incorporated in 2005 and is based in Kurnool, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Sree Rayalaseema Hi-Strength Hypo Limited reported revenue of ₹6.7B in FY2026 versus ₹12.6B in FY2022, a compound −14.7%/yr. Reported net income was ₹901M in FY2026, compounding −3.2%/yr from FY2022.
Is SRHHYPOLTD fairly valued? → Check now
Similar stocks
6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | €425.60 | €106.89 | -75% |
| Shin-Etsu Chemical Co SHECY | $22.43 | $14.26 | -36% |
| BASF SE BAS | €47.98 | €23.76 | -50% |
| Ningxia Baofeng Energy Group 600989 | ¥21.72 | ¥42.42 | +95% |
| Dow Inc D1OW34 | R$41.12 | R$16.66 | -59% |
| Ganfeng Lithium Group 002460 | ¥67.60 | ¥22.08 | -67% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD) undervalued?
What is the fair value of SRHHYPOLTD?
What is the quality score of SRHHYPOLTD?
What is the revenue of Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD)?
What is the net profit margin of SRHHYPOLTD?
Does Sree Rayalaseema Hi-Strength Hypo Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.